Regionally Focused in: Houston, Dallas, Little Rock, NOLA, Des Moines, Omaha
Serving as a field-based extension of Medical Affairs, the Medical Science Liaison (MSL) will represent the Company and their novel, first in class therapy, investigational compound being evaluated for a rare and chronic autoimmune disorder. The MSL will build long term peer to peer relationships with thought leaders, payers and other stakeholders within the medical hematology/oncology and transplant community to deliver clinical, scientific, and technical education.
The MSL will identify, develop and maintain effective professional relationships with critical customers in a specified geography in an effort to build and maintain a repository of Key Opinion Leaders for research initiatives, advisory boards and other opportunities for collaboration. These compliant scientific exchanges will support and/or expand current therapeutic concepts, as well as ensure the safe and effective utilization of Company product(s).